Showing results (21-30 of 960) with videos related to
Sort By:
Pageof 96
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III studyW Scheithauer, G Kornek, A Marczell, et al.Digestion|July 8, 1999
Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileumF Pfeffel, W Stiglbauer, D Depisch, et al.Cancer|June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinomaH Ulrich-Pur, G V Kornek, M Raderer, et al.British Journal of Cancer|April 17, 2003
Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinomaH Ulrich-Pur, M Raderer, G Verena Kornek, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trialW Scheithauer, B Schüll, H Ulrich-Pur, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1992
Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignanciesG V Kornek, D Depisch, H R Rosen, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1997
Treatment of advanced colorectal cancer with doxorubicin combined with two potential multidrug-resistance-reversing agents: high-dose oral tamoxifen and dexverapamilG Weinländer, G Kornek, M Raderer, et al.Cancer|October 1, 1992
A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreasW Scheithauer, F Pfeffel, G Kornek, et al.Transplantation|November 27, 1996
Serum tumor markers after renal transplantationR Oberbauer, S Banyai, A Schmidt, et al.British Journal of Cancer|October 1, 1993
MDR1 gene expression in primary colorectal carcinomasR Pirker, J Wallner, A Gsur, et al.Pageof 96